SCHEMBL14715166

SCHEMBL14715166

N#CCCN(Cc1cnc(N2CCOCC2)nc1)C(O)=S.NC(O)=S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 9/20 0.41
▸ POLB P06746 1/20 0.40
▸ HSD17B10 Q99714 7/20 0.39
▸ ALDH1A1 P00352 7/20 0.39
▸ CYP1A2 P05177 6/20 0.39
▸ CASP1 P29466 6/20 0.39
▸ CASP7 P55210 6/20 0.39
▸ HPGD P15428 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CYP3A4 P08684 2/20 0.36
▸ HIF1A Q16665 2/20 0.36
▸ USP2 O75604 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14715164 0.87 HSD17B10 (0.40) AOC3POLBHSD17B10ALDH1A1CYP1A2
SCHEMBL14973719 0.75 GAA (0.43) POLBALDH1A1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL14973632 0.70 L3MBTL1 (0.51) POLBALDH1A1CYP1A2MAPK1TP53
SCHEMBL14715116 0.70 ALDH1A1 (0.45) POLBALDH1A1CYP1A2HPGDTP53
SCHEMBL14974309 0.69 GAA (0.44) POLBALDH1A1CYP1A2HPGDMEN1
SCHEMBL14974220 0.69 ALDH1A1 (0.57) HSD17B10ALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL14982903 0.68 ALDH1A1 (0.39) AOC3POLBHSD17B10ALDH1A1CYP1A2
SCHEMBL14974605 0.68 ALDH1A1 (0.45) POLBALDH1A1CYP1A2HPGDMEN1
SCHEMBL14973980 0.68 ALDH1A1 (0.36) ALDH1A1CYP1A2CYP2C19SMN1; SMN2CYP3A4
SCHEMBL14715161 0.68 GAA (0.39) POLBALDH1A1CYP1A2CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF PEKING UNIVERSITY (CN) 2013-05-30 — — US claimed
EP-2562157-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF Peking University (CN) 2013-02-27 — — EP claimed
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF PEKING UNIVERSITY (CN) 2013-05-30 — — US disclosed
EP-2562157-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF Peking University (CN) 2013-02-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF LTK, ERBB2, ABL1 AOC3 3454/4885POLB 2417/4885HSD17B10 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback